Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS)
CNY 5.32
(-0.56%)
CNY 5.32
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.06 Billion | 1.96 Billion | 1.6 Billion | 1.41 Billion | 1.31 Billion | 1.19 Billion |
| Cost of Revenue | 1.53 Billion | 1.48 Billion | 1.14 Billion | 1.04 Billion | 827.45 Million | 792.64 Million |
| Gross Profit | 538.56 Million | 472.08 Million | 463.06 Million | 374.87 Million | 484.36 Million | 402.15 Million |
| Operating Expenses | 520.55 Million | 429.45 Million | 305.97 Million | 262.45 Million | 348.95 Million | 318.75 Million |
| Selling, General and Administrative Expenses | 351.35 Million | 229.85 Million | 171.09 Million | 141.23 Million | 213.61 Million | 167.43 Million |
| Research and Development Expenses | 127.71 Million | 116.51 Million | 56.49 Million | 63.66 Million | 59.38 Million | 58.11 Million |
| Other Expenses | 38.31 Million | 83.08 Million | 78.38 Million | 57.55 Million | 75.96 Million | -2.22 Million |
| Cost and Expenses | 2.02 Billion | 1.91 Billion | 1.44 Billion | 1.3 Billion | 1.17 Billion | 1.11 Billion |
| Operating Income | 44.16 Million | 27.46 Million | 130.77 Million | 119.93 Million | 139.55 Million | -113.11 Million |
| Interest Expense | 917.43 Thousand | 62.98 Million | 82.13 Million | 74.44 Million | 64.05 Million | 58.12 Million |
| Income Tax Expense | -1.86 Million | -7.13 Million | 671.4 Thousand | 1.64 Million | 6.26 Million | 117.46 Thousand |
| Earnings before Tax | 42.96 Million | -82.84 Million | 7.45 Million | 29.23 Million | 51.23 Million | -115.34 Million |
| Net Income | 43.55 Million | -75.71 Million | 5.99 Million | 29.24 Million | 45.71 Million | -115.31 Million |
| Earnings Per Share Basic | 0.08 | -0.13 | 0.01 | 0.05 | 0.08 | -0.20 |
| Earnings Per Share Diluted | 0.08 | -0.13 | 0.01 | 0.05 | 0.08 | -0.20 |
| Weighted Average Shares Outstanding | 562.74 Million | 566.68 Million | 560.31 Million | 546.55 Million | 555.87 Million | 573.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 562.74 Million | 566.68 Million | 560.31 Million | 546.55 Million | 555.87 Million | 574 Million |
| Gross Margin | 0.26 | 0.24 | 0.29 | 0.26 | 0.37 | 0.34 |
| EBIT Margin | 0.05 | 0.05 | 0.12 | 0.11 | 0.14 | 0.12 |
| Profit Margin | 0.02 | -0.04 | 0.00 | 0.02 | 0.03 | -0.10 |
| EBITDA | 111.8 Million | 90.44 Million | 187.95 Million | 142.46 Million | 98.64 Million | 141.38 Million |
| Earnings Before Tax Margin | 0.02 | 0.01 | 0.08 | 0.08 | 0.11 | -0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 413.42 Million | 425.29 Million | 499.11 Million | 2.05 Billion | 623.42 Million | 448.95 Million |
| Cost of Revenue | 319.37 Million | 309.91 Million | 362.61 Million | 1.53 Billion | 434.66 Million | 327.68 Million |
| Gross Profit | 94.04 Million | 115.37 Million | 136.49 Million | 528.63 Million | 188.75 Million | 121.27 Million |
| Operating Expenses | 92.21 Million | 96.89 Million | 110.66 Million | 443.95 Million | 118 Million | 92.42 Million |
| Selling, General and Administrative Expenses | 157.89 Million | 65.99 Million | 85.28 Million | - | 86.59 Million | 121.57 Million |
| Research and Development Expenses | 16.96 Million | 33.56 Million | 24.27 Million | - | 22.91 Million | 22.27 Million |
| Other Expenses | -82.64 Million | 2.66 Million | -2000.00 | -3.17 Million | -8.49 Million | 82.67 Thousand |
| Cost and Expenses | 411.59 Million | 406.81 Million | 473.27 Million | 1.97 Billion | 552.67 Million | 420.11 Million |
| Operating Income | 2.82 Million | 18.48 Million | 16.89 Million | 84.68 Million | 70.75 Million | 27.51 Million |
| Interest Expense | 39.99 Million | 13.5 Million | 13.7 Million | 51.79 Million | 13.48 Million | 12.91 Million |
| Income Tax Expense | -1.25 Million | -642.32 Thousand | -3.62 Million | -1.86 Million | -397.43 Thousand | 4.08 Million |
| Earnings before Tax | 2.65 Million | 7.31 Million | 16.89 Million | 51.28 Million | 68 Million | 27.39 Million |
| Net Income | 2.27 Million | 5.35 Million | 21.25 Million | 43.55 Million | 60.48 Million | 21.4 Million |
| Earnings Per Share Basic | 0.00 | 0.01 | 0.04 | - | 0.11 | 0.04 |
| Earnings Per Share Diluted | 0.00 | 0.01 | 0.04 | - | 0.11 | 0.04 |
| Weighted Average Shares Outstanding | 554.66 Million | 554.66 Million | 557.96 Million | 562.74 Million | 559.36 Million | 559.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 554.66 Million | 554.66 Million | 557.96 Million | 562.74 Million | 559.36 Million | 559.36 Million |
| Gross Margin | 0.23 | 0.27 | 0.27 | 0.26 | 0.30 | 0.27 |
| EBIT Margin | 0.10 | 0.09 | 0.06 | - | 0.14 | 0.06 |
| Profit Margin | 0.01 | 0.01 | 0.04 | 0.02 | 0.10 | 0.05 |
| EBITDA | 42.65 Million | 37.5 Million | 27.74 Million | - | 89.24 Million | 26.78 Million |
| Earnings Before Tax Margin | 0.01 | 0.04 | 0.03 | 0.04 | 0.11 | 0.06 |
EMIL-PREF
MDI
CNNRF
MAGNAELQ
ALUR
CHGZ